Skip to main content

November/December 2008, Vol 1, No 9

e-Prescribing: A Move Toward Appropriate Medication Use

Jack E. Fincham, PhD, RPh

Industry Trends

Focus on Lowest Net Cost Drug Reduces Costs for Patients, Plan Sponsors

Dana H. Felthouse, MBA

Erythropoiesis-Stimulating Agents in a Meta-Stable State: Guidelines, Economics, and Policy in Flux

Stakeholder Perspective

The Clinical and Economic Complexity of Biologics

by F. Randy Vogenberg, PhD, FASHP

Role for Automated Communication Strategies in Medication Adherence Management

S. Michael Ross, MD, MHA

Stakeholder Perspective

Efficient Automated Call System Improves Adherence, but What about Net Costs?

by Geoffrey P. Cole, MD, MBA

The Obama Administration and the FDA

Conference Highlights AHA

The Antiplatelet Drug Pipeline: Some Promising Candidates

Conference Highlights AMCP

Specialty Pipeline Dominated by Biologics

Conference Highlights AMCP

Real-World Data Better than RCTs for Formulary Decisions

An Overview of Cholesterol Management

Robyn A. Burns Schaiff, PharmD, BCPS, Richard M. Moe, MD, PhD, Daniel W. Krichbaum, PharmD

Stakeholder Perspective

Experts Debate Meaning of JUPITER for Clinical Practice

by Wayne Kuznar

Medical Tourism

Promotion of Medical Tourism in the Media Creates a Trend

J. Warren Salmon, PhD

Results 1 - 10 of 10